Prosecution Insights
Last updated: July 05, 2026

Examiner: SELWANES, JOHN PAUL

Tech Center 1600 • Art Units: 1651 1657

This examiner grants 44% of resolved cases

Performance Statistics

43.5%
Allow Rate
-16.5% vs TC avg
94
Total Applications
+57.4%
Interview Lift
1341
Avg Prosecution Days
Based on 62 resolved cases, 2023–2026

Rejection Statute Breakdown

4.6%
§101 Eligibility
9.4%
§102 Novelty
60.8%
§103 Obviousness
9.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17920142 METHOD AND DEVICE FOR ASSESSING A STATUS OF A WOUND OF A PATIENT Non-Final OA PAUL HARTMANN AG
18441878 E3 UBIQUITIN LIGASE (UBE3A) PROTEIN TARGETS Non-Final OA Hoffmann-La Roche Inc.
17607718 INDUSTRIAL FERMENTATION PROCESS FOR MICROBIAL CELLS USING A FED-BATCH PRE-CULTURE Non-Final OA BASF SE
17331723 ELECTROANALYTICAL DETERMINATION OF LEUKOCYTE ESTERASE Final Rejection Board of Regents, the University of Texas System
17280882 Multi-Use Fermentation Products Obtained Through Production of Sophorolipids Non-Final OA Locus Solutions IPCo, LLC
17796769 A METHOD FOR ISOLATING A MICROORGANISM Final Rejection TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
17314502 METHOD, DEVICE, AND KIT FOR POPULATION SCREENING FOR CANCER, CANCER RECURRENCE AND PRECANCEROUS CONDITIONS IN SYMPTOM FREE INDIVIDUALS Non-Final OA CANCER PREVENTION, LLC
18840008 METHOD FOR CARRYING OUT THE COMBINED OPERATION OF A BIOETHANOL PRODUCTION UNIT AND A BIOGAS UNIT Non-Final OA Novozymes A/S
16766189 Small Enzyme Particles For Interesterification Final Rejection Novozymes A/S
18560260 ENZYMES, HOST CELLS, AND METHODS FOR PRODUCTION OF ROTUNDONE AND OTHER TERPENOIDS Non-Final OA MANUS BIO INC.
18560883 ENGINEERED CELLS, ENZYMES, AND METHODS FOR PRODUCING CANNABINOIDS Non-Final OA Cellibre, Inc.
18697203 ENGINEERED LIPASE ENZYMES, MANUFACTURE AND USE THEREOF Non-Final OA Anagram Therapeutics, Inc.
18689550 PREPARATION METHOD OF ECHINOCANDIN NUCLEUS Non-Final OA BIOCON LIMITED
17639729 Production of Sialylated Oligosaccharides in Bacillus Cells Non-Final OA Chr. Hansen A/S
17054950 USE OF GLYCOSIDASES IN THE PRODUCTION OF OLIGOSACCHARIDES Final Rejection Chr. Hansen A/S
17798720 IN-VITRO DIAGNOSIS OF HISTAMINE INTOLERANCE SYNDROME Non-Final OA IMMUNDIAGNOSTIK AG
17795487 TEST AND IN VITRO DIAGNOSIS OF IRRITABLE BOWEL SYNDROME Non-Final OA IMMUNDIAGNOSTIK AG
18284708 METHOD FOR PRODUCING ANTIBODY-DRUG CONJUGATE AND ENZYME USED FOR THE SAME Non-Final OA MicroBiopharm Japan Co., Ltd.
17916414 A METHOD OF DIAGNOSING AND/OR PROGNOSING PREECLAMPSIA Final Rejection UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN
18315169 PROCESS FOR THE RECOVERY OF MICROALGAE USING MAGNETIC NANOPARTICLES OF BACTERIAL ORIGIN Non-Final OA UNIVERSIDADE FEDERAL DO RIO DE JANEIRO
17907162 NON INVASIVE METHODS FOR DIAGNOSING LIVER FIBROSIS Final Rejection King's College Hospital NHS Foundation Trust
17608255 RESPIRATORY INFECTION DETECTION AND CLASSIFICATION Non-Final OA AROCELL AB
16965324 PLANT MICROBIAL PREPARATIONS, COMPOSITIONS AND FORMULATIONS COMPRISING SAME AND USES THEREOF Non-Final OA Lavie Bio Ltd
14124535 Spray-Dried Lactobacillus Stems/Cells and the Use of Same Against Helicobacter Pylori Final Rejection ORGANOBALANCE GMBH

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month